Testing effectiveness (Phase 2)Study completedNCT02814097
What this trial is testing
Evaluate the Effects of 4 Weeks Treatment With Subcutaneous Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Preserved Ejection Fraction
Who this might be right for
Chronic Heart Failure
Stealth BioTherapeutics Inc. 46